Metabolic modulation of pyruvate dehydrogenase and glucose oxidation in diabetic cardiomyopathy: pathways, perspectives, and potentials
- 1 November 2025
- journal article
- review article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 329 (5) , H1142-H1153
Abstract
Individuals living with obesity and/or type 2 diabetes (T2D) are at a disproportionately high risk of developing cardiovascular disease. This includes diabetic cardiomyopathy (DbCM), a condition characterized by left ventricular diastolic dysfunction that is often present in individuals with pre- or early-stage T2D. Although there are numerous mediators that contribute to the development of DbCM, perturbations in cardiac substrate metabolism are widely believed to play a major role in its pathogenesis. In particular, myocardial glucose oxidation is often suppressed due to decreased activity of the pyruvate dehydrogenase (PDH) complex, the rate-limiting enzyme of glucose oxidation, which is responsible for decarboxylating pyruvate to acetyl CoA, thus acting as the link between glycolysis and oxidative phosphorylation of glucose. Importantly, numerous preclinical studies suggest that restoring suppressed myocardial glucose oxidation can alleviate DbCM. In this review, we will describe the major perturbations that characterize myocardial substrate metabolism in T2D, while discussing the primary pharmacological approaches that have been pursued to stimulate myocardial PDH activity and glucose oxidation. We will also highlight potential mechanisms explaining how increasing myocardial PDH activity and glucose oxidation favorably influence diastolic function. Given the increasing prevalence of DbCM in the human population, it is not only imperative to better understand its pathophysiology but also to develop novel therapies for its management, which may also have utility in the management of heart failure with preserved ejection fraction.Keywords
Funding Information
- Diabetes Canada
- Canada Research Chairs
- Canadian Government | Canadian Institutes of Health Research
- Ministry of Education of the People's Republic of China
This publication has 94 references indexed in Scilit:
- Epidemiology of heart failure in diabetes: a disease in disguiseDiabetologia, 2024
- Metabolic, structural and biochemical changes in diabetes and the development of heart failureDiabetologia, 2022
- Regulation of cardiac O-GlcNAcylation: More than just nutrient availabilityBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2020
- Dichloroacetate-induced peripheral neuropathy2019
- Potentiation of abnormalities in myocardial metabolism with the development of diabetes in women with obesity and insulin resistanceJournal of Nuclear Cardiology, 2011
- Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitusThe American Journal of Cardiology, 2004
- Inhibition of Glutathione S-Transferase ζ and Tyrosine Metabolism by Dichloroacetate: A Potential Unifying Mechanism for Its Altered Biotransformation and ToxicityBiochemical and Biophysical Research Communications, 1999
- Role of diabetes in congestive heart failure: The Framingham studyThe American Journal of Cardiology, 1974
- New type of cardiomyopathy associated with diabetic glomerulosclerosisThe American Journal of Cardiology, 1972
- Function of calcium ions in pyruvate dehydrogenase phosphatase activityBiochemical and Biophysical Research Communications, 1972